Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles D Thompson

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Genes|June 27, 2024
Innovations in Phenotyping and Diagnostics Create Opportunities for Improved Treatment and Genetic Counseling for Rare DiseasesMiles D Thompson
Genes|May 25, 2024
Rare Genetic Developmental Disabilities: Mabry Syndrome (MIM 239300) Index Cases and Glycophosphatidylinositol (GPI) DisordersMiles D Thompson, Alexej Knaus
Alcohol and Alcoholism (Oxford, Oxfordshire)|August 28, 2015
Variation in the Serotonin Transporter Gene and Alcoholism: Risk and Response to PharmacotherapyMiles D Thompson, George A Kenna
Sub-Cellular Biochemistry|July 30, 2015
Neurogenetic Aspects of Hyperphosphatasia in Mabry SyndromeDavid E C Cole, Miles D Thompson
The American Journal of Clinical Nutrition|January 1, 2009
Vitamin B-12 and neural tube defects: the Canadian experienceMiles D Thompson, David E C Cole, Joel G Ray
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Pharmacogenomics of G protein-coupled receptor signaling: insights from health and diseaseMiles D Thompson, David E C Cole, Pedro A Jose
Critical Reviews in Clinical Laboratory Sciences|November 12, 2005
The G protein-coupled receptors: pharmacogenetics and diseaseMiles D Thompson, W McIntyre Burnham, David E C Cole
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
G protein-coupled receptor pharmacogeneticsMiles D Thompson, Katherine A Siminovitch, David E C Cole
Frontiers in Neuroscience|May 17, 2014
OX1 and OX2 orexin/hypocretin receptor pharmacogeneticsMiles D Thompson, Henri Xhaard, Takeshi Sakurai, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 13, 2016
Cellular signalling of cysteinyl leukotriene type 1 receptor variants CysLT₁-G300S and CysLT₁-I206SLouiza Yaddaden, Steeve Véronneau, Miles D Thompson, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Genes|June 27, 2024
Innovations in Phenotyping and Diagnostics Create Opportunities for Improved Treatment and Genetic Counseling for Rare DiseasesMiles D Thompson
Genes|May 25, 2024
Rare Genetic Developmental Disabilities: Mabry Syndrome (MIM 239300) Index Cases and Glycophosphatidylinositol (GPI) DisordersMiles D Thompson, Alexej Knaus
Alcohol and Alcoholism (Oxford, Oxfordshire)|August 28, 2015
Variation in the Serotonin Transporter Gene and Alcoholism: Risk and Response to PharmacotherapyMiles D Thompson, George A Kenna
Sub-Cellular Biochemistry|July 30, 2015
Neurogenetic Aspects of Hyperphosphatasia in Mabry SyndromeDavid E C Cole, Miles D Thompson
The American Journal of Clinical Nutrition|January 1, 2009
Vitamin B-12 and neural tube defects: the Canadian experienceMiles D Thompson, David E C Cole, Joel G Ray
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Pharmacogenomics of G protein-coupled receptor signaling: insights from health and diseaseMiles D Thompson, David E C Cole, Pedro A Jose
Critical Reviews in Clinical Laboratory Sciences|November 12, 2005
The G protein-coupled receptors: pharmacogenetics and diseaseMiles D Thompson, W McIntyre Burnham, David E C Cole
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
G protein-coupled receptor pharmacogeneticsMiles D Thompson, Katherine A Siminovitch, David E C Cole
Frontiers in Neuroscience|May 17, 2014
OX1 and OX2 orexin/hypocretin receptor pharmacogeneticsMiles D Thompson, Henri Xhaard, Takeshi Sakurai, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 13, 2016
Cellular signalling of cysteinyl leukotriene type 1 receptor variants CysLT₁-G300S and CysLT₁-I206SLouiza Yaddaden, Steeve Véronneau, Miles D Thompson, et al.
Pageof 4